Jun 03, 2026
1:100
For every 100 shares held, investors received 1. The price per share adjusted from $0.06 to $6.08.
The split itself did not change the total investment value.
Active Biotech AB (STO:ACTI) operates in the Biotechnology industry.
Active Biotech AB company overviewActive Biotech AB's most recent stock split was on June 3, 2026. It was a 1-for-100 reverse split, so shareholders received 1 share for every 100 they held.
Active Biotech AB (STO:ACTI) has split its stock 11 times: a 37-for-36 split on June 8, 2005, a 595-for-516 split on May 18, 2009, a 1059-for-1000 split on December 3, 2014, a 418-for-411 split on November 17, 2016, a 294-for-221 split on March 23, 2018, a 81-for-68 split on December 30, 2020, a 25-for-24 split on August 17, 2022, a 680-for-611 split on November 15, 2023, a 423-for-191 split on October 25, 2024, a 765-for-607 split on November 20, 2025, and a 1-for-100 reverse split on June 3, 2026.
Active Biotech AB has split its stock 11 times. This history records 11 splits between June 8, 2005 and June 3, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Active Biotech AB's 1-for-100 reverse split on June 3, 2026, every 100 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Active Biotech AB has not announced a new split in our records. Its most recent split was on June 3, 2026, less than a year ago. Companies announce splits in advance, and any new STO:ACTI split will appear on this page.
Already premium?